Bozkurt Murat
Ankara Yildirim Beyazit University, School of Medicine, Department of Orthopaedics and Traumatology and Department of Musculoskeletal System and Regenerative Medicine, Ankara, Turkey.
Arthrosc Tech. 2022 Apr 22;11(5):e767-e773. doi: 10.1016/j.eats.2021.12.035. eCollection 2022 May.
Meniscal allograft transplantation (MAT) has proven successful in relieving joint pain and providing functional improvement in patients who have undergone subtotal or total meniscectomy. Bone marrow aspirate concentrate (BMAC) is a biological adjuvant that was shown in the literature to be effective in treating cartilage damage and muscle-tendon tissue problems. The aim of the study is the concomitant use of MAT and BMAC, which are both considered biological treatments and would be beneficial in clinical practice.
半月板同种异体移植(MAT)已被证明在缓解接受半月板次全切除术或全切除术患者的关节疼痛和改善功能方面是成功的。骨髓抽吸浓缩物(BMAC)是一种生物佐剂,文献表明其在治疗软骨损伤和肌腱组织问题方面有效。本研究的目的是同时使用MAT和BMAC,这两种方法均被视为生物治疗方法,在临床实践中可能有益。